Related Experiment Video
Updated: Jul 24, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
Britni Baxter1, Shayla Sanders, Shilpa A Patel
1Altus Infusion/Houk Rheumatology, Little Rock, Arkansas (Ms Baxter); Premier Specialty Network, Columbia, Missouri (Ms Sanders); and Horizon Therapeutics PLC, Deerfield, Illinois (Ms Patel, Ms Martin, and Mr West).
Abstract:
Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse's role in patient education, serum uric acid monitoring, and patient medication compliance is essential for ensuring patient safety and maximizing the number of patients who benefit from a full treatment course of pegloticase. Infusion nurses are on the front lines with patients and need to be educated on potential negative effects associated with the medications they infuse, such as infusion reactions, as well as risk management methods like patient screening and monitoring. Further, patient education provided by the infusion nurse plays a large role in empowering the patient to become their own advocate during pegloticase treatment. This educational overview includes a model patient case for pegloticase monotherapy, as well as one for pegloticase with immunomodulation and a step-by-step checklist for infusion nurses to refer to throughout the pegloticase infusion process. A video abstract is available for this article at http://links.lww.com/JIN/A105.
Related Concept Videos
Urinary Tract Calculi V: Nursing Management
Endocarditis IV: Nursing Management
Nephrotic Syndrome III : Nursing Management
Kidney Transplant III: Nursing Management
Urinary Tract Infection IV: Nursing Management
Peripheral Artery Disease IV: Nursing Management

